Vimarsana
Biggest News Aggregation in the World

Page 9 - Johnson Amp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Johnson Amp Today - Breaking & Trending Today

Johnson & Johnson (NYSE:JNJ) Receives Consensus Rating of "Hold" from Brokerages - Vimarsana News

Johnson & Johnson (NYSE:JNJ) Receives Consensus Rating of "Hold" from Brokerages

Shares of Johnson & Johnson (NYSE:JNJ – Get Free Report) have received a consensus recommendation of “Hold” from the twelve analysts that are presently covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price […]

Business News: FDA clears Moderna's and Pfizer's Covid vaccine booster shots for all U.S. adults - Vimarsana News

Business News: FDA clears Moderna's and Pfizer's Covid vaccine booster shots for all U.S. adults

FDA clears Moderna's and Pfizer's Covid vaccine booster shots for all U.S. adults : Rashtra News Liesl Eibschutz, a medical student from Dartmouth University, loads a syringe with Pfizer COVID-19 vaccine before giving it to people on the first day that people ages 16 and up can receive the vaccine at Kedren Health on Thursday,

Jim Cramer: Amazon and Dell are benefiting the most from Nvidia partnership - Vimarsana News

Jim Cramer: Amazon and Dell are benefiting the most from Nvidia partnership

Jim Cramer reflects on Nvidia's GTC conference and identifies the companies that stand to gain the most through partnerships with the AI chip giant.

Source: cnbc.com
U.S. FDA Approves OPSYNVI® (macitentan and tadalafil) as the First and Only Once-Daily Single-Tablet Combination Therapy for Patients with Pulmonary Arterial Hypertension (PAH) - Vimarsana News

U.S. FDA Approves OPSYNVI® (macitentan and tadalafil) as the First and Only Once-Daily Single-Tablet Combination Therapy for Patients with Pulmonary Arterial Hypertension (PAH)

OPSYNVI® combines two proven treatments with established efficacy and safety profiles into one tablet to be taken once daily, offering an option that helps to...

West Paces Advisors Inc. Sells 177 Shares of Johnson & Johnson (NYSE:JNJ) - Vimarsana News

West Paces Advisors Inc. Sells 177 Shares of Johnson & Johnson (NYSE:JNJ)

West Paces Advisors Inc. lowered its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.6% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 3,642 shares of the company’s stock after selling 177 shares during the period. West Paces Advisors Inc.’s holdings in Johnson […]